- Home
- GALT vs GEOS Comparison
GALT vs GEOS Comparison
Compare GALT & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- GEOS
- Stock Information
- Founded
- GALT 2000
- GEOS 1980
- Country
- GALT United States
- GEOS United States
- Employees
- GALT N/A
- GEOS N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- GEOS Industrial Machinery/Components
- Sector
- GALT Health Care
- GEOS Industrials
- Exchange
- GALT Nasdaq
- GEOS Nasdaq
- Market Cap
- GALT 83.5M
- GEOS 72.9M
- IPO Year
- GALT N/A
- GEOS 1997
- Fundamental
- Price
- GALT $2.80
- GEOS $10.61
- Analyst Decision
- GALT Buy
- GEOS
- Analyst Count
- GALT 2
- GEOS 0
- Target Price
- GALT $6.00
- GEOS N/A
- AVG Volume (30 Days)
- GALT 1.5M
- GEOS 510.4K
- Earning Date
- GALT 08-12-2025
- GEOS 08-07-2025
- Dividend Yield
- GALT N/A
- GEOS N/A
- EPS Growth
- GALT N/A
- GEOS N/A
- EPS
- GALT N/A
- GEOS N/A
- Revenue
- GALT N/A
- GEOS $116,542,000.00
- Revenue This Year
- GALT N/A
- GEOS N/A
- Revenue Next Year
- GALT N/A
- GEOS N/A
- P/E Ratio
- GALT N/A
- GEOS N/A
- Revenue Growth
- GALT N/A
- GEOS N/A
- 52 Week Low
- GALT $0.73
- GEOS $5.51
- 52 Week High
- GALT $3.90
- GEOS $18.99
- Technical
- Relative Strength Index (RSI)
- GALT 67.38
- GEOS 45.20
- Support Level
- GALT $2.07
- GEOS $12.80
- Resistance Level
- GALT $2.36
- GEOS $13.11
- Average True Range (ATR)
- GALT 0.24
- GEOS 1.25
- MACD
- GALT 0.03
- GEOS -0.60
- Stochastic Oscillator
- GALT 81.11
- GEOS 0.74
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About GEOS Geospace Technologies Corporation (Texas)
Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.